((3S,4R)-4-(4-Fluorophenyl)piperidin-3-yl)methanol, 95.0%, 1g

1-(2-Chlorophenyl)-3-methyl-1H-pyrazol-5(4H)-one, 95.0%, 5g

(2,2-Dimethyl-1,3-dioxan-5-yl)methanol, 98.0%, 5g

7-Nitroisoquinolin-1(2H)-one, 95.0%, 100mg

2-Bromo-1-(2,6-difluorophenyl)ethanone, 95.0%, 10g

Benzofuran-2-carboximidic acid ethyl ester; hydrochloride, 95.0%, 5g

2-(4-Methylthiazol-5-yl)ethyl butyrate, 95.0%, 5g

N-[(1R*,4R*)-4-Aminocyclohexyl]-3-bromobenzamide hydrochloride, 1g

4-(3,4-Dimethoxybenzyl)piperidine, 95%, 1g

Microliter syringe MICROLITER® series 7000 Point type 2, 0.5 µl, 7000.5 KH, 1 Piece

1-Phenyl-1H-pyrazol-5-amine, 95.0%, 5g

BIS(3-(HYDROXYMETHYL)AZETIDIN-3-OL); OXALIC ACID, 95.0%, 250mg

2-Fluorobenzyl Cyanide>97.0%(GC)25g